ASLM’s COVID-19 ECHO Sessions

View the latest of ASLM’S COVID-19 ECHO SESSIONS


      

COVID-19 ECHO Sessions


Session 1

Troubleshooting Common Challenges Associated with SARS-CoV-2 Diagnostic Test Establishment

Session 2

Latest Update On Available Technology to Detect COVID-19

Session 3

The Korean Experience for the African Continent

Session 4

Manufacturers of COVID-19 Molecular Diagnostic Tests: BD and Cepheid

Session 5

Manufacturers of COVID-19 Molecular Diagnostic Tests: QIAGEN & Thermo Fisher Scientific

Session 6

Serology Tests and Their Role in the Pandemic Response

Session 7

Implementing Fast Turn-Around Laboratory Testing for Control of COVID-19

Session 8

Manufacturers of Molecular Diagnostics Tests Pt3: Abbott and Bio-Rad

Session 9

Diagnostics in the COVID-19 Pandemic Response

Session 10

Best Practices Implementing a Structured Quality Assured Testing Program

Session 11

Procurement and Supply Chain for COVID-19 Diagnostics

Session 12

Facial Masks During COVID-19: Homemaking, Disinfection and Imaging

Session 13

Manufacturers of COVID-19 Molecular Diagnostics Tests: Abbott Serology in the Core Lab and Analytics

Session 14

Specimen Referral Systems for SARS-CoV-2 Testing

Session 15

Manufacturers of COVID-19 Molecular Diagnostics Tests: KH Medical Co., Ltd., South Korea & Inqaba Biotec

Session 16

Manufacturers of COVID-19 Molecular Diagnostics Tests: PerkinElmer & Pro-Med Diagnostics, South Africa

Session 17

Manufacturers of COVID-19 Molecular Diagnostics Tests: EUROIMMUN AG, Germany and Hologic, USA

Session 18

Manufacturers of COVID-19 Molecular Diagnostics Tests: Roche Diagnostics International Ltd.

Session 19

Public Health Lab Networks and SARS-CoV-2 Testing: Challenges, Strategies, and Lessons from the USA

Session 20

Laboratory Data Management Considerations for COVID-19 Response

Session 21

Optimised Diagnostic Networks Key to Responding to COVID-19: Doing More with Less

Session 22

Self-Collection of Nasal Specimens: Lowering the Barrier to SARS-CoV-2 Testing and Access to Care

Session 23

COVID-19 Antigen Testing’s Role in the Helping Control the Pandemic

Session 24

COVID-19 Testing Project – Independent Evaluation Results: What Do We Know About Performance?

Session 25

Considerations of Pooling Specimens for COVID-19 Testing by Real-Time RT-PCR

Session 26

Unpacking the Global Launch of COVID-19 Ag-RDT Testing

Session 27

Digital solutions supporting healthcare providers and stakeholders in their COVID-19 response

Session 28

Manufacturers of COVID-19 Rapid Diagnostics Tests: Abbott Panbio SARS-CoV-2 Antigen Rapid Test

Session 29

Manufacturers of COVID-19 Rapid Diagnostics Tests: STANDARD Q COVID-19 Antigen Rapid Test

Session 30

Funding & Procurement Mechanisms for SARS-CoV-2 Antigen Rapid Tests

Session 31

Manufacturers of COVID-19 Rapid Diagnostics Tests: LumiraDx SARS-CoV-2 Antigen Assay

Session 32

Launch of SARS-CoV-2 Antigen Rapid Test Training Package


Session 33

Testing Strategy for COVID-19 Antigen Rapid Diagnostic Tests

Session 34

Manufacturers of COVID-19 Rapid Diagnostics Tests: BD (USA) and DiaSorin (Italy)

Session 35

Expanding COVID-19 testing to reopen economies: A panel discussion

Session 36

Genomic Surveillance of SARS-CoV-2 in South Africa: Implications on Transmission and Vaccine Efficacy

Session 37

African Experience on Expanding COVID-19 Testing Using SARS-CoV-2 Antigen Rapid Diagnostic Tests

Session 38

Impact of Novel Variants on COVID-19 Diagnostics

Session 39

Outcomes, Successes and Lessons from Implementing Emergency SARS-CoV-2 EQA Proficiency Testing in Africa

Session 40

Manufacturers of COVID-19 Diagnostic Products: Thermo Fisher solutions for new SARS-CoV-2 variants

Session 41

Africa CDC Trusted Travel Platform: Creating a Trusted Network of Covid-19 Testing Laboratories

Session 42

Manufacturers of COVID-19 Diagnostic Products:  Abbott Rapid Diagnostics and Beckman Coulter Inc.

Waste Management Training


May 2020 Waste Management Training

COVID-19 Biosafety Guidance for Laboratories Confirmation

LabCoP ECHO Session


June 2020 LabCoP ECHO Session

Key Considerations for Differentiated Service Delivery in the Context of the Global COVID-19 Pandemic

July 2020 LabCoP ECHO Session

 No Time to Wait! Demand Creation for Early Infant Diagnosis of HIV

August 2020 LabCoP ECHO Session

EQA Proficiency Testing Coverage, Results and Sustainability from the Perspective of a Service Provider

Special LabCoP ECHO Session

Establishing Diagnostic Connectivity for Laboratory Network Data Flow Across Conventional & POC Systems

September 2020 LabCoP ECHO Session

Using Strategic Communications as a Tool for Social Change and Advocacy

October 2020 LabCoP ECHO session

Operationalising the M&E Sub-community of Practice: Improving M&E for HIV/TB and Emerging Challenges

January 2021 LabCoP ECHO Session

PEPFAR Country Operational Plan (COP) 2021: laboratory systems strengthenin

1st LabCoP Extended Echo Session

Launch of the Score-TB Package

February 2021 LabCoP Extended ECHO Session

Roche & CDC Partnership: Developing Capacity and Improving Efficiencies in Laboratory Operations

March 2021 LabCoP Extended ECHO Session

Leveraging Laboratory Information Management Systems in the COVID-19 Pandemic:

March 2021 LabCoP ECHO Session

New WHO Recommendations for Clinical and Service Delivery of HIV Prevention, Treatment and Care



Last modified: Thursday, April 29, 2021, 10:18 AM